Skip to main content
SciBase's melanoma detection device wins FDA approval

SciBase obtained approval from the FDA for Nevisense, a device designed to facilitate detection of early stages of malignant melanoma. The device, which conducts skin assessment using electrical signals, may be used for prebiopsy assessment of suspicious skin lesions that have at least one characteristic of melanoma, but it should not be used for confirming a clinical diagnosis of melanoma.

Full Story: